Century Therapeutics Inc (NASDAQ:IPSC) price on current trading day, rose 6.29% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.52.
A look at the stock’s price movement, the close in the last trading session was $1.43, moving within a range at $1.43 and $1.58. The beta value (5-Year monthly) was 1.42. Turning to its 52-week performance, $5.51 and $1.14 were the 52-week high and 52-week low respectively. Overall, IPSC moved 9.35% over the past month.
Century Therapeutics Inc’s market cap currently stands at around $129.24 million, with investors looking forward to this quarter’s earnings report slated for in January.
Analysts have a consensus estimate of 975k for the company’s revenue for the quarter, with a low and high estimate of 100k and 2M respectively. The average forecast suggests up to a 263.81% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 3.29M, representing a 47.16% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that IPSC is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 3 recommend IPSC as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
IPSC’s current price about 8.61% and 5.53% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 54.65, while 7-day volatility ratio is 10.10% and 9.83% in the 30-day chart. Further, Century Therapeutics Inc (IPSC) has a beta value of 1.66, and an average true range (ATR) of 0.14. Analysts have given the company’s stock an average 52-week price target of $5, forecast between a low of $5 and high of $5. Looking at the price targets, the low is -228.95% off current price level while to achieve the yearly target high, price needs to move -228.95%. Nonetheless, investors will most likely welcome a -228.95% jump to $5 which is the analysts’ median price.
If we refocus on Century Therapeutics Inc (NASDAQ:IPSC), historical trading data shows that trading volumes averaged 0.76 over the past 10 days and 442.65K over the past 3 months. The company’s latest data on shares outstanding shows there are 84.76 million shares.
The 59.56% of Century Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 31.01% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.26 million on 2024-11-15, giving us a short ratio of 5.47. The data shows that as of 2024-11-15 short interest in Century Therapeutics Inc (IPSC) stood at 325.0 of shares outstanding, with shares short falling to 3.33 million registered in 2024-10-15. Current price change has pushed the stock -54.22% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the IPSC stock continues to rise going into the next quarter.
